Table 2 Complement C3 levels in the all studied cases
From: Complement C3 as a potential NAFLD predictor in an Egyptian cohort with diabetes and/or obesity
Parameters | Group 1 Control group (N=14) | Group II Obese-diabetic (N=15) | Group III Diabetic Non-obese group (N=14) | Group IV Obese Non-diabetic group (N=12) |
|---|---|---|---|---|
Complement C3 (g/l) | 0.927±0.289 | 1.698±0.29 | 1.36±0.28 | 1.48±0.174 |
P value between each group and group I | P<0.001** | P<0.001** | P<0.001** | |
P value between each group and group II | P<0.001** | P=0.036* | ||
P value between each group and group III | P=0.260 |